150 related articles for article (PubMed ID: 36175596)
21. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
23. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
24. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
25. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
26. SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production.
Dou C; Xu Q; Liu J; Wang Y; Zhou Z; Yao W; Jiang K; Cheng J; Zhang C; Tu K
J Exp Clin Cancer Res; 2019 Feb; 38(1):70. PubMed ID: 30755243
[TBL] [Abstract][Full Text] [Related]
27. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z
Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734
[TBL] [Abstract][Full Text] [Related]
28. MiR-892a Promotes Hepatocellular Carcinoma Cells Proliferation and Invasion Through Targeting CD226.
Jia B; Tan L; Jin Z; Jiao Y; Fu Y; Liu Y
J Cell Biochem; 2017 Jun; 118(6):1489-1496. PubMed ID: 27883251
[TBL] [Abstract][Full Text] [Related]
29. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
30. Sex Comb on Midleg Like-2 Accelerates Hepatocellular Carcinoma Cell Proliferation and Metastasis by Activating Wnt/β-Catenin/EMT Signaling.
Du L; Wang L; Yang H; Duan J; Lai J; Wu W; Fan S; Zhi X
Yonsei Med J; 2021 Dec; 62(12):1073-1082. PubMed ID: 34816637
[TBL] [Abstract][Full Text] [Related]
31. miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.
Chen K; Li Z; Zhang M; Wang B; Peng T; Shen Y; Zhang J; Ye J; Liu Y; Tang D; Peng M; Ma D; Xiao Z; Zhang Y; Jin W; Li X
Biomed Res Int; 2020; 2020():1964219. PubMed ID: 33083453
[TBL] [Abstract][Full Text] [Related]
32. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
33. Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells.
Shi K; Ru Q; Zhang C; Huang J
Med Sci Monit; 2018 Mar; 24():1642-1653. PubMed ID: 29557391
[TBL] [Abstract][Full Text] [Related]
34. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
36. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
37. Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2.
Hu JJ; Zhou C; Luo X; Luo SZ; Li ZH; Xu ZX; Xu MY
J Exp Clin Cancer Res; 2021 Jan; 40(1):26. PubMed ID: 33422101
[TBL] [Abstract][Full Text] [Related]
38. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
Han L; Huang C; Zhang S
Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
[TBL] [Abstract][Full Text] [Related]
39. CD36: The Bridge between Lipids and Tumors.
Zhou X; Su M; Lu J; Li D; Niu X; Wang Y
Molecules; 2024 Jan; 29(2):. PubMed ID: 38276607
[TBL] [Abstract][Full Text] [Related]
40.
Zheng J; Luo J; Zeng H; Guo L; Shao G
Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]